2018.09.28
License Agreement Has Been Entered with Stem Cell & Device Laboratory, Inc. (SCAD)
License-Out
We executed a non-exclusive license agreement with SCAD for providing their products related to iPS cell-derived cardiomyocytes for research use, on the patents related to iPS cell technology that have been sublicensed to us by Kyoto University.